DaVita
DVA
₹12,591
Share price
0.10%
Change (1 day)
8.03%
Change (1 year)
Categories
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.
Revenue for DaVita (DVA)
Revenue in 2025 (TTM): ₹1.097 Trillion
According to DaVita's latest financial reports the company's current revenue (TTM 
) is ₹1.123 Trillion. In 2024 the company made a revenue of ₹1.099 Trillion an increase over the revenue in the year 2023 that were of ₹1.010 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for DaVita from 1996 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | ₹1.097 T | -0.18% |
| 2024 | ₹1.099 T | 8.78% |
| 2023 | ₹1.010 T | 5.2% |
| 2022 | ₹960.71 B | 11.09% |
| 2021 | ₹864.80 B | 2.37% |
| 2020 | ₹844.74 B | 4.02% |
| 2019 | ₹812.12 B | 1.84% |
| 2018 | ₹797.45 B | 14.83% |
| 2017 | ₹694.48 B | -25.56% |
| 2016 | ₹932.93 B | 1.86% |
| 2015 | ₹915.87 B | 12.94% |
| 2014 | ₹810.92 B | 11.58% |
| 2013 | ₹726.78 B | 63.16% |
| 2012 | ₹445.43 B | 23.04% |
| 2011 | ₹362.03 B | 25.35% |
| 2010 | ₹288.81 B | 1.89% |
| 2009 | ₹283.44 B | 4.19% |
| 2008 | ₹272.05 B | 31.69% |
| 2007 | ₹206.59 B | -4.43% |
| 2006 | ₹216.16 B | 66.87% |
| 2005 | ₹129.54 B | 30.13% |
| 2004 | ₹99.54 B | 6.84% |
| 2003 | ₹93.17 B | 4.76% |
| 2002 | ₹88.93 B | 11.66% |
| 2001 | ₹79.65 B | 14.82% |
| 2000 | ₹69.36 B | 10.42% |
| 1999 | ₹62.82 B | 22.63% |
| 1998 | ₹51.23 B | 149.64% |
| 1997 | ₹20.52 B | 109.26% |
| 1996 | ₹9.80 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Tenet Healthcare THC | ₹1.778 T | 58.23% | 🇺🇸 USA |
 Pediatrix Medical Group MD | ₹171.23 B | -84.76% | 🇺🇸 USA |
 Universal Health Services
UHS | ₹1.393 T | 24.02% | 🇺🇸 USA |
 LabCorp LH | ₹1.141 T | 1.61% | 🇺🇸 USA |